摘要
血管局部定位基因转染是目前血管再狭窄基因治疗研究的热点,它将特异性基因精确定位转染至局部血管壁,实现外源性基因表达,从而最大限度地在血管局部发挥生物学效应。血管内支架作为一种局部定位并长期保留在体内的外源性植入物,是对血管内再狭窄进行基因治疗的比较理想的运载体系。
出处
《中国动脉硬化杂志》
CAS
CSCD
2006年第1期83-85,共3页
Chinese Journal of Arteriosclerosis
参考文献30
-
1Fischman DL,Leon MB,Baim DS,Schatz RA,Savage MP,Penn I,et al.A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease,Stent Restenosis Study Investigators[J].N Engl J Med,1994,331 (8):496-501 被引量:1
-
2Serruys PW,Foley DP,Suttorp MJ,Rensing BJ,Suryapranata H,Materne P,et al.A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions:final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study[J].J Am Coll Cardiol,2002,39 (3):393-399 被引量:1
-
3van den Brand MJ,Rensing BJ,Morel MA,Foley DP,de Valk V,Breeman A,et al.The effect of completeness of revascularization on event-free survival at one year in the ARTS trial[J].J Am Coll Cardiol,2002,39 (4):559-564 被引量:1
-
4El-Omar MM,Dangas G,Iakovou I,Mehran R.Update on In-stent Restenosis[J].Curr Interv Cardiol Rep,2001,3 (4):296-305 被引量:1
-
5Kipshidze N,Leon MB,Tsapenko M,Falotico R,Kopia GA,Moses J.Update on sirolimus drug-eluting stents[J].Curr Pharm Des,2004,10 (4):337-348 被引量:1
-
6Stone GW,Ellis SG,Cox DA,Hermiller J,O'Shaughnessy C,Mann JT,et al.A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease[J].N Engl J Med,2004,350 (3):221-231 被引量:1
-
7Liistro F,Colombo A.Late acute thrombosis after paclitaxel eluting stent implantation[J].Heart,2001,86 (3):262-264 被引量:1
-
8Yla-Herttuala S,Martin JF.Cardiovascular gene therapy[J].Lancet,2000,355 (9199):213-222 被引量:1
-
9Mann MJ,Whittemore AD,Donaldson MC,Belkin M,Conte MS,Polak JF,et al.Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy:the PREVENT single-centre,randomised,controlled trial[J].Lancet,1999,354 (9189):1 493-498 被引量:1
-
10Sharif F,Daly K,Crowley J,O'Brien T.Current status of catheter-and stent-based gene therapy[J].Cardiovasc Res,2004,64 (2):208-216 被引量:1
二级参考文献37
-
1周玉杰,汪丽蕙,周爱儒,朱晓君,王文革,张晨辉,汤健.反义N-ras1基因对血管损伤后平滑肌细胞增殖的影响[J].中华医学杂志,1997,77(3):220-223. 被引量:8
-
2Chang M W, Barr E, Liu M M, et al. Adenovirusmediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty[J]. J Clin Invest,1995, 96(5): 2260. 被引量:1
-
3Asahara T, Bauters C, Pastore C, eta/. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery[J]. Circulation, 1995, 91(11): 2793. 被引量:1
-
4Morishita R, Aoki M, Kaneda Y, et al. Gene therapy in vascular medicine: recent advances and future perspectives [J]. Pharmacol Ther, 2001, 91 (2): 105. 被引量:1
-
5Elkon K B, Liu C C, Gall J G, et al. Tumor necrosis factor plays a central role in immune-mediated clearance of adenoviral vectors[J]. Proc Natl Acad Sci USA, 1997,94(18): 9814. 被引量:1
-
6Zhang H G, Zhou T, Yang P, et al. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver[J].Hum Gene Ther, 1998, 9(13): 1875. 被引量:1
-
7Muul L M, Tuschong L M, Soenen S L, et al. Persistence and expression of the adenosine deaminase gene for twelve years and immune reaction to gene transfer components: Long-term results of the first clinical gene therapy trial[J], Blood, 2003, 101 (7): 2563. 被引量:1
-
8Minter R M, Ferry M A, Murday M E, et al. Adenoviral delivery of human and viral IL-10 in murine sepsis [J]. J Immunol, 2001, 167(2): 1053. 被引量:1
-
9Su E J, Stevenson S C, Rollence M, et al. A genetically modified adenoviral vector exhibits enhanced gene transfer of human smooth muscle cells [J]. J Vasc Res, 2001, 38(5): 471. 被引量:1
-
10Yoshimura I, Ikegami S, Suzuki S, et al. Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system [J]. J Urol, 2002, 168(6):2659. 被引量:1
共引文献24
-
1金旭,朱敦皖,冷希岗,张超,王海,姚康德,宋存先.十二烷基化壳聚糖基因支架血管内基因转运的实验研究[J].生物医学工程与临床,2006,10(S1):342-345.
-
2高展,慕朝伟,高润霖,阮英茆,孟亮,司文学,王清峙.改进的明胶蛋白涂层支架用于小型猪冠状动脉转染一氧化氮合酶基因的可行性研究[J].中国循环杂志,2004,19(z1):57-59.
-
3郑金刚,高润霖,程树军,王春宁,钱杰,阮英茆,王清峙,袁晋青,孟亮,乔树宾,陈纪林.可降解雷帕霉素洗脱支架对猪冠状动脉支架置入术后内膜增生的影响[J].中国循环杂志,2004,19(3):190-193. 被引量:9
-
4陆程翔,陈炳煌.血管内皮生长因子基因预防冠心病介入治疗术后再狭窄的研究进展[J].心血管病学进展,2005,26(1):55-58.
-
5张文辉,金小海.药物涂层支架涂层的工艺[J].国际生物医学工程杂志,2006,29(1):42-44. 被引量:3
-
6金旭,朱敦皖,张超,唐丽娜,王海,柏金根,姚康德,宋存先.十二烷基化壳聚糖基因支架血管内基因转运的实验研究[J].生物医学工程与临床,2006,10(6):342-345. 被引量:2
-
7张琳华,张超,宋存先,金旭,罗彤,罗鹏,高润霖.血管支架固定化抗体携带和靶向投递基因研究[J].中国动脉硬化杂志,2008,16(6):424-428. 被引量:1
-
8武清敏,乔钦增,赵卫林,王立峰,张永红,郭全合,常增义.药物洗脱支架和内皮细胞种植支架的生物相容性[J].中国组织工程研究与临床康复,2008,12(35):6927-6930. 被引量:4
-
9赵艳,王禹.康复运动与冠状动脉支架置入血管后再狭窄[J].中国组织工程研究与临床康复,2010,14(17):3181-3184. 被引量:9
-
10龙腾河,廖明壮,罗焕江,董刚志.冠状动脉支架材料类型与置入后的效果评价[J].中国组织工程研究与临床康复,2010,14(25):4725-4728. 被引量:5
同被引文献58
-
1赵安莎,张海燕,黄楠,张炳春,杨柯,李占全,赵红岩.载药复合支架的抗血管组织增生的研究[J].生物医学工程学杂志,2008,25(4):856-859. 被引量:6
-
2Regar E,Serruys PW,Bode C,et al.Angiographic findings of the multicenter randomized study with the sirolimus-eluting bx velocity balloon-expandable stent(ravel)[J].Circulation,2002,106:1949-1956. 被引量:1
-
3Cohen DJ,Bakhai A,Shi C,et al.Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses:results from the sirolimus-eluting balloon expandable stent in the treatment of patients With De Novo native coronary artery lesions(sirius)trial[J].Circulation,2004,110:508-514. 被引量:1
-
4Wiemer M,Knig A,Rieber J,et al.Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions:clinical and ultrasound results from a randomised trial[J].Euro Intervention,2011,6:687-694. 被引量:1
-
5von Neumann-Cosel P.Electron capture radioactive sources for intravascular brachytherapy:a feasibility study[J].Phys Med Biol,2003,48:1855-1862. 被引量:1
-
6Sharif F,Daly K,Crowley J,O'Brien T.Current status of catheter-and stent-based gene therapy[J].Cardiovasc Res,2004,64 (2):208-216 被引量:1
-
7Klugherz BD,Jones PL,Cui X,Chen W,Meneveau NF,DeFelice S,et al.Gene delivery from a DNA controlled-release stent in porcine coronary arteries[J].Nature Biotechnol,2000,18 (11):1 181-184 被引量:1
-
8Mann MJ,Whittemore AD,Donaldson MC,Belkin M,Conte MS,Polak JF,et al.Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy:the prevent single-centre,randomised,controlled trial[J].Lancet,1999,354 (9189):1 493-498 被引量:1
-
9Asahara T,Bauters C,Pastore C,Kearney M,Rossow S,Bunting S,et al.Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery[J].Circulation,1995,91 (11):2 793-801 被引量:1
-
10Harvey BG,Maroni J,O'Donoghue KA,Chu KW,Muscat JC,Pippo AL,et al.Safety of local delivery of low-and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions[J].Hum Gene Ther,2002,13 (1):15-63 被引量:1
引证文献5
-
1金旭,宋存先,Robert J Levy,Bruce D Klugherz,Suzanne De Felice.冠状动脉支架固定化抗体携带基因和靶向基因投递[J].中国动脉硬化杂志,2006,14(7):573-576. 被引量:1
-
2邱志兵,万松.预防静脉桥狭窄的新策略[J].中国动脉硬化杂志,2008,16(3):238-240. 被引量:4
-
3王文俊,刘季春.静脉桥血管材料——大隐静脉移植后再狭窄的治疗进展[J].中国组织工程研究与临床康复,2010,14(53):10011-10016. 被引量:2
-
4第七届中国西部介入放射学术会议纪要(成都2011)[J].介入放射学杂志,2011,20(8):651-651.
-
5王燕,段峰,李志伟,王茂强.预防血管内支架植入术后再狭窄的研究进展[J].介入放射学杂志,2011,20(8):665-668. 被引量:8
二级引证文献15
-
1倪达,薛松,连锋,王维俊.PDGF通过AKT/FoxO信号通路促进血管平滑肌细胞增殖[J].中国分子心脏病学杂志,2011,11(6):346-349. 被引量:2
-
2张琳华,张超,宋存先,金旭,罗彤,罗鹏,高润霖.血管支架固定化抗体携带和靶向投递基因研究[J].中国动脉硬化杂志,2008,16(6):424-428. 被引量:1
-
3许欢,陈鑫,邱志兵,段超.组织贴块法培养大鼠主动脉平滑肌细胞及鉴定[J].医学研究杂志,2009,38(11):64-66. 被引量:6
-
4郑辉,薛松.冠状动脉旁路移植术后静脉桥再狭窄的基因治疗研究进展[J].国际遗传学杂志,2010,33(6):364-368.
-
5胡金朋,浦奎,王津胜,郭峰,胡渝生.药物洗脱支架治疗老年多支冠状动脉狭窄122例[J].中国老年学杂志,2012,32(6):1287-1288. 被引量:1
-
6杨晓虎,林裕辉,徐欣,范隆华.锁骨下动脉狭窄或闭塞腔内治疗25例疗效分析[J].中国临床研究,2019,32(1):57-60. 被引量:6
-
7李菁,王珏,朱悦琦,张培蕾.巴曲酶联合阿司匹林预防糖尿病下肢缺血病变介入术后再狭窄的疗效分析[J].介入放射学杂志,2014,23(10):865-869. 被引量:5
-
8郭占芳,梁向党,孙赓,余宽宽,蔡宏飞,邹秀强.3种血管外支架预防静脉移植再狭窄效果对比研究[J].现代中西医结合杂志,2015,24(13):1369-1371. 被引量:2
-
9张红.探讨巴曲酶联合阿司匹林预防糖尿病下肢缺血病变介入术后再狭窄的疗效[J].糖尿病新世界,2015,35(9):11-11.
-
10毛红岩.经桡动脉与经股动脉介入治疗静脉桥血管病变100例[J].中国处方药,2016,14(2):143-144.
-
1董民,李玉卿.胃幽门联合支架治疗胃体胃癌28例体会[J].中国科技信息,2005(12):144-144.
-
2何国祥,刘建平,景涛,唐兵.血管紧张素Ⅱ及其受体在血管再狭窄中作用的研究[J].科学中国人,2006(10):88-89.
-
3罗海明.防止介入治疗后血管再狭窄[J].中国老年,2011(12):56-56.
-
4赵宏伟 ,贾云 ,刘火安 ,戴传云 .血管内支架内皮化研究进展[J].重庆科技学院学报:自然科学版,2005,7(1):58-60.
-
5刘子懿.miR-145——心血管疾病新的治疗靶点[J].生理科学进展,2010,41(6):477-477.
-
6韩伟,刘闺男.平滑肌细胞基因治疗血管再狭窄的新进展[J].心血管病学进展,2007,28(5):753-756. 被引量:1
-
7董霞,朱敦皖,宋丽萍,刘兰霞,张海玲,冷希岗.人脐动脉平滑肌细胞培养及转染TFPI基因的实验研究[J].国际生物医学工程杂志,2010,33(5):293-296. 被引量:1
-
8宋丽萍,楼莎,朱敦皖,刘兰霞,张海玲,董霞,董庭婷,冷希岗.组织因子途径抑制因子/绿色荧光蛋白双顺反子真核表达载体构建及其在NIH 3T3细胞中表达[J].生物医学工程与临床,2011,15(2):178-182.
-
9周道奇.电子植入物使盲人重见光明[J].知识就是力量,2006(10):4-5.
-
10刘苏健,邓勇志,马捷.大鼠Pik3cb shRNA质粒的构建及鉴定[J].山西医科大学学报,2007,38(9):769-773.